5-Amino-1MQ: The NNMT Inhibitor in Fat Loss and Longevity Research
5-Amino-1MQ is a small molecule that blocks the NNMT enzyme to raise cellular NAD+ and shrink fat cells in research models. Here's the mechanism and what studies show.
5-Amino-1MQ is not a peptide — it is a small molecule — but it has become a fixture in the metabolic and longevity research space because of an unusual mechanism: it raises cellular NAD+ from a completely different angle than the popular NAD+ precursors.
What Is 5-Amino-1MQ?
5-Amino-1MQ (5-amino-1-methylquinolinium) is a selective inhibitor of the enzyme NNMT (nicotinamide N-methyltransferase). NNMT is overexpressed in adipose tissue and in some aging and metabolic-disease states. By inhibiting it, 5-Amino-1MQ has been studied for its effects on fat cell metabolism and NAD+ availability.
How Does 5-Amino-1MQ Work?
NNMT consumes methyl groups and NAD+-related substrate to methylate nicotinamide. When it is overactive, two things happen: cellular energy metabolism slows in fat tissue, and NAD+ salvage is impaired. Inhibiting NNMT has been researched for the reverse effects:
- ·Raises cellular NAD+ — frees up nicotinamide for the NAD+ salvage pathway rather than shunting it to methylation
- ·Increases adipocyte energy expenditure — in preclinical models, blocking NNMT reduced fat cell size and increased metabolic rate
- ·Distinct from NAD+ precursors — precursors like NMN and NR supply raw material; 5-Amino-1MQ instead removes a drain on the system
This "different lever" is why some researchers study it alongside NAD+ precursors rather than as a replacement. See our NAD+ precursors guide for the complementary side of that pathway.
What Does the Research Show?
Preclinical studies reported that NNMT inhibition reduced adipose tissue mass and improved metabolic parameters in diet-induced obesity models, without reducing food intake — pointing to an energy-expenditure mechanism rather than appetite suppression. This contrasts with GLP-1 agonists like Semaglutide, which work primarily by reducing intake. Much of the 5-Amino-1MQ data is still preclinical, and human research is early.
How Researchers Use It
Unlike most compounds in this catalog, 5-Amino-1MQ is often studied via oral administration in research models because of its small-molecule structure. It is frequently paired conceptually with NAD+ and body-composition research protocols.
Available at JA Performance
5-Amino-1MQ is stocked at high purity, verified by independent third-party testing. For the broader NAD+ and longevity picture, see NAD+ and the longevity collection.
Note: 5-Amino-1MQ is sold strictly for laboratory and in vitro research purposes. Not for human consumption.